Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease

In atherosclerosis; blood low-density lipoproteins (LDL) are subjected to multiple enzymatic and non-enzymatic modifications that increase their atherogenicity and induce immunogenicity. Modified LDL are capable of inducing vascular inflammation through activation of innate immunity; thus, contribut...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Orekhov, Alexander N., Bobryshev, Yuri V., Sobenin, Igor A., Melnichenko, Alexandra A., Chistiakov, Dimitry A.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2014
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4139876/
https://ncbi.nlm.nih.gov/pubmed/25050779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms150712807
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky